15 July, 2024 ‘IMRP 2024 Conference: What to Expect’ Webinar for the Chinese irradiation communityThe iia is pleased to announce that it will be hosting a live webinar to introduce and discuss the 21st International Meeting on Radiation Processing (IMRP 2024) to the Chinese irradiation ...
13 October, 2024 IMRP 2024 Sponsor Spotlight: Aerial The iia would like to thank Aerial, a Ruby Sponsor of IMRP 2024, for their support and contribution towards the success of this year's conference. “Aerial, French Technology Resources Centre, is proud to be Ruby Sponsor of the next Int...
Conference Highlights Written by Physician-Scientist South-Central Section of the American Urological Association SCS AUA 2024 SCS AUA 2024: Financial Toxicity in Testicular Cancer Treatment, Validated Questionnaire Correlated Software Cost Modeling SCS AUA 2024: Multiparametric MRI in the Evaluation of Sma...
The collaboration will accelerate the global development of LAE102, a novel Activin Receptor Type 2 A (ActRIIA) Antagonistic Monoclonal Antibody (mAb) for muscle-preservingweight loss in Obesity LOS ANGELES, Nov. 20, 2024 /PRNewswire/ -- Laekna, Inc. (2105.HK) ("Laekna"), a global biotech...
The collaboration will accelerate the global development of LAE102, a novel Activin Receptor Type 2 A (ActRIIA) Antagonistic Monoclonal Antibody (mAb) for muscle-preservingweight loss in Obesity LOS ANGELES, Nov. 20, 2024 /PRNewswire/ -- Laekna, Inc. (2105.HK) ("Laekna"), a global biotech...
ArticleOpen access31 March 2024 Introduction Thrombosis is a common pathophysiological condition underlying strokes, ischemic heart disease, peripheral arterial disease, and deep vein thrombosis. Thrombi are generated as a final product of the coagulation cascade. The reaction of the coagulation cascade is...
Conference Highlights Written by Physician-Scientist South-Central Section of the American Urological Association SCS AUA 2024 SCS AUA 2024: Financial Toxicity in Testicular Cancer Treatment, Validated Questionnaire Correlated Software Cost Modeling SCS AUA 2024: Multiparametric MRI in the Evaluation of Sma...
Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial * Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives ...
IONISOS, a member of iia, has been working with partners on the development of 2 interesting applications of gamma irradiation. The first project involves the gamma irradiation of natural fibres that can be used to reinforce composite materials. This technology is an alternative to chemical or ...
The collaboration will accelerate the global development of LAE102, a novel Activin Receptor Type 2 A (ActRIIA) Antagonistic Monoclonal Antibody (mAb) for muscle-preservingweight loss in Obesity LOS ANGELES, Nov. 20, 2024 /PRNewswire/ -- Laekna, Inc. (2105.HK) ("Laekna"), a global ...